Source: PENNSYLVANIA STATE UNIVERSITY submitted to NRP
ROLE OF IMMUNE CELLS IN THE ESTABLISHMENT AND ACTIVATION OF THE OVARIAN RESERVE
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
1032077
Grant No.
2024-67015-42293
Cumulative Award Amt.
$300,000.00
Proposal No.
2023-08311
Multistate No.
(N/A)
Project Start Date
Jul 1, 2024
Project End Date
Jun 30, 2026
Grant Year
2024
Program Code
[A1211]- Animal Health and Production and Animal Products: Animal Reproduction
Recipient Organization
PENNSYLVANIA STATE UNIVERSITY
408 Old Main
UNIVERSITY PARK,PA 16802-1505
Performing Department
(N/A)
Non Technical Summary
Reproductive problems remain the number one reason for involuntary culling on dairy farms, creating increased economc costs on farms and increased environmental impacts of dairy farming. The total number of eggs in the ovary is established before birth and is nonrenewing. The goal of this project is to generate an improved understanding of the ovarian developmental events that impactfertility over the lifespan. The global hypothesis is that the immune system interacts with the developing ovary to direct the total number and quality of eggs in the ovary at birth and thus the lifetime fertility potential of the ovary.Aim 1 is to investigate how the immune system regulates the death or survival of eggs in the developing ovary. Aim 2 is to investigate how the immune system regulates when eggs and their supporting cells begin to grow. This project will lead to an improved understanding of how the ovary develops and how this impacts long-term fertility. A role for immune cells in early ovarian developmental events suggests a link between ovarian development and whole-body health-- perhaps cows that experienced disease as young calves or were gestated by dams that experienced disease during pregnancy will have reduced ovarian reserve as compared to healthy calves or those from healthy dams.The long-term goal of this project is to improve understanding of ovarian development in cattle, to improve reproductive efficiency. Ultimately, the knowledge generated by this project will be applied to improve reproductive management on dairies, making dairy farming more sustainable and dairy products more economical.
Animal Health Component
(N/A)
Research Effort Categories
Basic
100%
Applied
(N/A)
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
3013410104050%
3013410109050%
Goals / Objectives
Infertility remains the top reason for involuntary culling on dairy farms, causing substantial financial losses and increasing environmental impacts. The ovarian reserve of follicles is established before birth in cattle, and its size and health are key determinants of lifetime fertility. During ovarian reserve establishment, most oocytes die, and those that remain are enclosed by granulosa cells and become follicles. After establishment, this reserve is nonrenewing and is progressively depleted through the reproductive lifespan, as follicles irreversibly activate, begin to grow, and ultimately ovulate. The processes of follicle assembly and activation are poorly understood. Immune cells are detectable in the developing ovary, but their functional roles are unknown. Given that immune cells are regulators of cell death and tissue remodeling, we hypothesize that they regulate these key processes during ovarian development, thus regulating the formation and depletion of the ovarian reserve. The goal of this project is to determine the role of immune cells in early ovarian developmental events, including oocyte attrition, follicle assembly, and follicle activation. The specific aims are:1. To investigate the effect of ovarian immune cells on oocyte attrition and primordial follicle assembly.2. To investigate the effect of ovarian immune cells on primordial follicle activation and growth.
Project Methods
Histology:Ovaries will be fixed, embedded, sectioned, and stained, and follicles will be quantified [26, 32]. Fetuses will be batched every 10 days (ie, day 50-day 59) beginning on day 50 [33] for statistical analysis, but exact age will be retained in the metadata, allowing precise evaluation of times that appear to be key transition points.Flow cytometry: Flow cytometry will be used to profile the immune cell subtypes in the developing ovary. Ovaries will be dissociatedand CD45+ cells will be sorted on a magnetic bead-based sorter. CD45+ cells will be assessed by flow cytometry, to determine relative proportions of immune cell subtypes. Populations of interest are monocytes (CD14), total macrophages (CD11B), proinflammatory M1 macrophages (NOS2, TNFA, CD80, CD86) and anti-inflammatory M2 macrophages (CD163, IL10)[36, 37], total T cells (CD3), T cell subtypes (CD4, CD8 and TCR delta) and B cells (pan-B cell antibody). These bovine-validated antibodies are available from the WSU antibody center, BioRad, or Thermo. Single cell sequencing:For this experiment, ovaries will be dissociated and CD45+ cells isolated, as above. The CD45+ and CD45- populations will be mixed at a 1:1 ratio to allow sequencing of a standard number of cells (~10,000), while still capturing the relatively rare immune cells in significant numbers. Results will be validated by a combination of qPCR and RNA in-situ hybridization.Immunohistochemistry: In this experiment, ovarian immune cell subtypes will be localized in the ovary, relative to oocytes, follicles, and vasculature, by immunohistochemistry. This will determine if immune cells colocalize preferentially with dying oocytes, nascent follicles, vasculature, or ovarian stroma. Cells undergoing death will be labeled with a TUNEL assay, a standard assay for assessing cellular death. Follicles will be labeled with FOXL2, a well-known granulosa cell marker, oocytes with DDX4, and vasculature with vWF.In vitro assays and Cell culture: Ovarian immune cell function will be assessed in vitro. Phagocytic ability of macrophages will be assessed using a commercially available kit. In addition to this assay, T cell proliferation will be assessed using a kit and cytokine production from macrophages, T cells, and ovarian cortex cultures (culture period: 24 hr) from the four stages of development previously described will be assessed using the Luminex Milliplex bovine cytokine/chemokine array. This assay allows the assessment of fifteen cytokines/chemokines, including IFNγ, IL-1α, IL-1β, IL-4, IL-6, IL-8 (CXCL8), IL-10, IL-17A, IL-36RA (IL-1F5), IP-10 (CXCL10), MCP-1 (CCL2), MIP-1α (CCL3), MIP-1β (CCL4), TNFα, VEGF-A. In addition, immune cells will be cocultured with oocytes or ovarian cortices to determine changes in oocyte/follicle survival in the presence of immune cells.

Progress 07/01/24 to 06/30/25

Outputs
Target Audience:The primary target audiences for this project are 1. Other researchers and sceintists in the fields of animal science and 2. Farmers and producers whose systems may ultimately be impacted by the findings. In this early stage of the project, other researchers scientists were reached through presentations of this work at the USDA PD meeting and my Hatch Multistate meeting. These presentations provided valuable opportunities to share the work and recieve feedback. In the next reporting period, we plan to publish this work in an academic journal. Changes/Problems:All experiments in this project are based onability to collect fetalovarian samples from a local slaughterhouse, Nicholas Meats. The collection of these samples was slower than anticipated, thus delaying several of the major experiments proposed, most notably the single cell sequencing experiments, and delaying our ability to submit publications. At this time, we now have all necessary samples (from all fetal age groups) for all IHC and RNA experiments banked in our lab, resulting from many trips to the slaughterhouse over the last year. Moreover, we haveregular trips to the slaughterhouse scheduled every two weeks, for the remainder of the project period. These will provide adequate samples for the in vitro and single cell experiments proposed. What opportunities for training and professional development has the project provided?This project has provided significant opportunities for professional development. 1. An undergraduate honors student was on this project and involved in sample collection, processing, and storage. This project provided opportunities for her to learn skills including tissue processing, sectioning, immunohistochemistry (IHC), RNA isolation, and qPCR. She also completed an honors thesis in my laboratory, providing an opportunityfor her to develop writing and communications skills. 2. Two undergraduate students just startedworking on this project and are learning skills including tissue culture, processing, and embedding. 3. A graduate student working on this project has developed significant numbers of new skills including laboratory skills (flow cytometry, IHC, tissue dissociation, tissue culture), experimental design and troubleshooting skills, presentation skills (from biweekly lab meetings) and bioinformatics skills. She has also submitted an abstract to a conference based on this project, and in the next reporting period, this conference presentation will be reported. 4. A technician working on this project has developed laboratory skills (dissection, tissue processing), organizational skills, and communication skills working with the local slaughterhouse we have used for tissue collection. 5. Given that this is a new investigator seed grant, the PD has had the opportunity to develop significant skills directing and leading a project and has given the presentations described below. How have the results been disseminated to communities of interest?1. Preliminary results were presented by the PD at the PI's Hatch Multistate meeting in Ohio in May 2025. This was to a group of peer reproductive biologists and provided an excellent opportunity to receive feedback on experiments in progress. 2. Preliminary results were presented by thePD at the USDA PD meeting in June. This also was to a group of peer reproductive biologists and also provided an excellent opportunity to receive feedback on experiments in progress.? What do you plan to do during the next reporting period to accomplish the goals?1. The single cell sequencing experiments will be performed. This will provide detailed information on both phenotypes and abundance of immune cell subtypes in the developing ovary and their interactions with other immune cell types. 2. In vitro ovarian cortical culture experiments will be completed to provide mechanistic information on immune cell effects on ovarian function, including oocyte death, primordial follicle assembly, and primordial follicle activation. 3. A manuscript detailing the first set of experiments is currently in preparation. It will be submitted during the next reporting period. The results will also be presented at the Society of the Study of Reproduction conference.

Impacts
What was accomplished under these goals? 1. We determined that PTPRC, the transcript encoding CD45 (a total immune cell marker) declines temporally in the developing ovary, at the same time as oocyte attritionand primordial follicle assembly. Indeed, the decline in PTPRC between fetal day 90 and fetal day 150is correlated with a decline in dead cells per section between fetal day 90 and fetal day 150. This suggests that the greater immune cell populations on day 90 are associated with, and perhaps driving,the greater oocyte death on day 90. We have also used immunohistochemistry and identified CD45 cells in the developing ovary, colocalizing with DDX4cells (oocytes). Quantification of CD45 cells by both flow cytometry and by counting CD45+ cells per section in IHC is currently underway. 2. We determined that markers of total T cells (CD3D) and T helper cells (CD4) do notchange during ovarian development, either at the time of primordial follicle assembly or at the time of follicular activation. In contrast, markers of CD8 cytotoxic cells do change.CD8 alpha beta T cells areclassical cytotoxic proinflammatory CD8 T cells, whereasCD8 alpha alphaT cells arehomeostatic pro-resolving CD8 T cells. Interestingly, CD8A increased with the process of ovarian development and was at its greatest abundance during follicular activation. In contrast, CD8B was most abundant during oocyte attrition and then declined by the time of follicular activation. This suggests that theremay be a switch from inflammatoryCD8AB to pro-resolving CD8AA cells as follicular assembly is completed. Experiments are underway to validate this by flow cytometry. 3. We determined that CD68, a macrophage marker, is most abundant in the ovary on day 120,during follicular assembly. Abundance of M1 proinflammatory and M2 pro-resolving macrophages was unchanged. We hypothesize that macrophages may be involved in phagocytosis or tissue remodeling in the ovary during this time. 4. We identified threecytokines that tended to decline between the time of follicular assembly (day 90-110) and the time of follicular activation (Day 175-200). These included the IL36 inhibitor IL36RA, the proinflammatory cytokine IL1A, and the immune cell chemotactic cytokine CCL2. In addition, CCL3, another immune cell chemotactic cytokine, tended to declinebetween day 120-135 and day 175-200. Overall, this suggests a more proinflammatory environment in the ovary during follicular assembly and a less inflammatory environment during early activation.

Publications